Loading...

Apellis Pharmaceuticals, Inc. (APLS) SEC Filings and Updates | Billiver

Official SEC filings

Apellis Pharmaceuticals, Inc. SEC Filings and Updates

A filing-level feed of official SEC EDGAR updates collected by Billiver. This page shows metadata and source links only; full filing text opens on SEC.gov.

Apellis Pharmaceuticals, Inc. Official SEC Updates

Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.

SEC 8-KMay 14, 2026

SEC 8-K: Item 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01

Official SEC filing update. Items: 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01.

Item 1.01, 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01Accession 0001193125-26-222923

Open SEC filing

SEC 10-QMay 7, 2026

SEC 10-Q

Official SEC filing update.

10-QAccession 0001492422-26-000108

Open SEC filing

SEC 8-KMay 4, 2026

SEC 8-K: Item 5.02

Official SEC filing update. Items: 5.02.

Item 5.02Accession 0001193125-26-202504

Open SEC filing

SEC 8-KMar 31, 2026

SEC 8-K: Item 1.01, 5.02, 8.01, 9.01

Official SEC filing update. Items: 1.01, 5.02, 8.01, 9.01.

Item 1.01, 5.02, 8.01, 9.01Accession 0001193125-26-134916

Open SEC filing

SEC 8-KMar 2, 2026

SEC 8-K: Item 5.02

Official SEC filing update. Items: 5.02.

Item 5.02Accession 0001193125-26-084156

Open SEC filing

SEC 10-KFeb 24, 2026

SEC 10-K

Official SEC filing update.

10-KAccession 0001193125-26-065179

Open SEC filing

SEC 8-KJan 12, 2026

SEC 8-K: Item 2.02, 9.01

Official SEC filing update. Items: 2.02, 9.01.

Item 2.02, 9.01Accession 0001193125-26-010540

Open SEC filing

SEC 10-QOct 30, 2025

SEC 10-Q

Official SEC filing update.

10-QAccession 0001193125-25-257374

Open SEC filing

SEC 10-QJul 31, 2025

SEC 10-Q

Official SEC filing update.

10-QAccession 0000950170-25-100545

Open SEC filing

SEC 8-KJul 1, 2025

SEC 8-K: Item 1.01

Official SEC filing update. Items: 1.01.

Item 1.01Accession 0001193125-25-153429

Open SEC filing

SEC 8-KJun 4, 2025

SEC 8-K: Item 5.07

Official SEC filing update. Items: 5.07.

Item 5.07Accession 0001193125-25-134886

Open SEC filing

SEC 10-QMay 7, 2025

SEC 10-Q

Official SEC filing update.

10-QAccession 0000950170-25-064976

Open SEC filing

SEC DEF 14AApr 23, 2025

SEC DEF 14A

Official SEC filing update.

DEF 14AAccession 0000950170-25-056966

Open SEC filing

SEC 8-KApr 21, 2025

SEC 8-K: Item 5.02, 9.01

Official SEC filing update. Items: 5.02, 9.01.

Item 5.02, 9.01Accession 0001193125-25-086304

Open SEC filing

SEC 10-KFeb 28, 2025

SEC 10-K

Official SEC filing update.

10-KAccession 0000950170-25-029507

Open SEC filing

Source: SEC EDGAR · 15 filings

Informational only. Not investment advice.